Login To Trade  |  About IIFL
  • NIFTY  7972.55  -29.4 -0.37%
  • SENSEX 26270.63  -121.75 -0.46%

Cipla cuts prices on 3 anti-cancer drugs: reports

India Infoline News Service | Mumbai | November 08, 2012 12:51 IST

Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.

Drug maker Cipla has reduced the prices on three anti-cancer drugs — Erlotinib (ERLOCIP), Docetaxel (DOCETAX) and Capecitabine (CAPEGARD), according to reports.

Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.

BSE 671.05 11.30 (1.71%)
NSE 671.50 11.65 (1.77%)

***Note: This is a NSE Chart


Get Top 500 Company Research from acclaimed IIFL Research Team...Click Here!!!

Read more on: Cipla   
article
113110704863
Cipla cuts prices on 3 anti-cancer drugs: reports
Cipla cuts prices on 3 anti-cancer drugs: reports
Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.
http://www.indiainfoline.com/article/news-top-story/cipla-cuts-prices-on-3-anti-cancer-drugs-reports-113110704863_1.html
November 08, 2012 12:51 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
Cipla
Others
$rawVideoFileUrl$
$videoPlayerUrl$
News
Recent Reports

Stability in US and Europe to aid export growth

India Infoline Research Team / 10:47, Aug 24, 2015

In spite of massive improvement in CV demand, standalone revenues for Banco Products Ltd registered muted performance with sales at Rs. 113cr in Q1 FY16.